ADO Properties S.A.

  • WKN: A14U78
  • ISIN: LU1250154413
  • Land: Luxemburg

Nachricht vom 23.01.2018 | 09:35

ADO Properties S.A. announces change to the Board of Directors

DGAP-News: ADO Properties S.A. / Key word(s): Change of Personnel

23.01.2018 / 09:35
The issuer is solely responsible for the content of this announcement.


Berlin, January 23, 2018 - ADO Properties S.A. announces that Mr. Yaron Karisi has stepped down as a member of the board of directors of ADO Properties S.A. as of December 30, 2017.

On January 22, 2018 the board of directors appointed Mr. Yuval Dagim as a member of the board of directors with immediate effect. Yuval Dagim has taken over the position as the CEO of Shikun & Binui, Israel, after the end of Yaron Karisis term. Yuval Dagim will initially be a member of the board of directors until the annual general meeting in 2018. Yaron Karisi was a member of the board of directors of ADO Properties S.A. since 2015.

Yuval Dagim (55) has vast leadership experience in global businesses in the industrial and the infrastructure sector. His previous positions include Managing Director of Quarry Products at Hanson in Britain, where he gained extensive experience in the field of construction materials. He also served as Managing Director at Kimberly Clark Israel, and as Managing Director at Kimberly Clark Australia and New Zealand.

The board of directors of ADO Properties S.A. thanks Yaron Karisi for his successful term and for performing his duty with responsibility, professionalism and commitment. The board wishes Yaron Karisi all the best for the future.



23.01.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

M1 Kliniken: Geschäftsjahr über den Erwartungen

Mit dem deutlichen Anstieg auf 21 Klinikstandorte (Ende 2016: 13) hat die auf ästhetische Medizin spezialisierte M1 Kliniken AG die Basis für einen Ausbau der Umsatz- und Ertragsbasis gelegt. Hinzu kommt die bereits in Umsetzung befindliche Erschließung weiterer Umsatzströme, wie etwa die Erweiterung der Eigenmarken oder die Abdeckung der ästhetischen Zahnmedizin. Das Kursziel beläuft sich auf 18,50 € und das Rating lautet KAUFEN.

News im Fokus

Vonovia SE: Vonovia veröffentlicht Angebotsunterlage zum Übernahmeangebot an die Aktionäre von Victoria Park (News mit Zusatzmaterial)

24. Mai 2018, 11:33

Aktueller Webcast

JOST Werke AG

Investor & Analyst Call Q1 2018

24. Mai 2018

Aktuelle Research-Studie

curasan AG

Original-Research: curasan AG (von Montega AG): Halten

25. Mai 2018